Recent Health Day News states, "Humira (adalimumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe ulcerative colitis in adults, the agency said Friday.
Humira -- a type of drug called an anti-tumor necrosis factor that's designed to suppress abnormal inflammatory and immune responses -- has already been approved to treat a host of conditions, including rheumatoid arthritis, Crohn's disease and plaque psoriasis." MORE 
Have you tried it? Is it helping?